General considerations for skin test procedures in the diagnosis of drug hypersensitivity
By K. Brockow, A. Romano, M. Blanca, J. Ring, W. Pichler, P. Demoly. Allergy. European Journal of Allergy and Clinical Immunology, 2002
769 citations recorded by the source corpus.
Subfields: Dermatology, Pharmacology, Physiology
View Paper: https://www.semanticscholar.org/paper/6496c0221ee74b53987e955c6a5f9198da9cf2ba
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- P. Demoly
- W. Aberer
- K. Brockow
- N. Adkinson
- W. Pichler
- A. Bircher
- M. Castells
- A. Romano
Citations in the corpus
- International Consensus on drug allergy (2014, background): “According to the clinical presentations, a hypothesis on pathogenesis should be generated (Table 2) in order to select appropriate testing procedures (12, 62).”
- Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations (2003, methodology): “Establish the diagnosis in cases of suggestive history but negative (skin or in vitro-) tests: For clarification of suspected drug hypersensitivity skin tests are usually the first to be performed (18,32), but frequently with negative results.”